Nanjing Dadong Pharmaceutical Technology

Nanjing Dadong Pharmaceutical Technology is a Chinese pharmaceutical technology company specializing in the research, development, and production of pharmaceutical intermediates and fine chemicals. Founded in 2016 and headquartered in Nanjing, the company operates an R&D center and a production base to support the synthesis of complex chemical entities. Their product portfolio primarily includes intermediates for cardiovascular, anti-tumor, and anti-viral medications, such as those used in the production of anticoagulants like Apixaban and Rivaroxaban. Nanjing Dadong provides custom synthesis and contract manufacturing services to global pharmaceutical and biotech partners.